Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Oct;7(3):73-74.
doi: 10.1055/s-0040-1721451. Epub 2020 Dec 7.

World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer

Qian Liu  1
Affiliations
Editorial

World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer

Qian Liu. Glob Med Genet. 2020 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

References

    1. Siegel R L, Miller K D, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(01):7–30. - PubMed
    1. Feng R M, Zong Y N, Cao S M, Xu R H. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun (Lond) 2019;39(01):22. - PMC - PubMed
    1. Molina J R, Yang P, Cassivi S D, Schild S E, Adjei A A. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(05):584–594. - PMC - PubMed
    1. Rusch T, Bayry J, Werner J, Shevchenko I, Bazhin A V. Immunotherapy as an option for cancer treatment. Arch Immunol Ther Exp (Warsz) 2018;66(02):89–96. - PubMed
    1. Rossi J F, Céballos P, Lu Z Y. Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells. Cancer Commun (Lond) 2019;39(01):34. - PMC - PubMed

Publication types